Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
64,97 USD | +0,02% | -.--% | +240,87% |
Omzet 2024 * | 17,7 mln. 16,32 mln. | Omzet 2025 * | 20,32 mln. 18,74 mln. | Marktkapitalisatie | 4,46 mld. 4,11 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -97 mln. -89,44 mln. | Nettowinst (verlies) 2025 * | -115 mln. -106 mln. | EV/omzet 2024 * | 231 x |
Nettoliquiditeiten 2024 * | 376 mln. 346 mln. | Nettoliquiditeiten 2025 * | 302 mln. 278 mln. | EV/omzet 2025 * | 204 x |
K/w-verhouding 2024 * |
-48,1
x | K/w-verhouding 2025 * |
-36,8
x | Werknemers | 142 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,04% |
Recentste transcriptie over Alpine Immune Sciences, Inc.
1 dag | +0,02% | ||
1 maand | +0,57% | ||
3 maanden | +80,47% | ||
6 maanden | +315,67% | ||
Lopend jaar | +240,87% |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.64% | 4 M€ | -5,15% | - | |
0.02% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - | |
0.00% | 9 M€ | +9,86% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+240,87% | 4,46 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |